This noncognitive-based algorithm should prove useful to identify HIV-infected patients with advanced disease at high risk of HAND who require more formal assessment. We propose staged guidelines, using the algorithm, for improved HAND therapeutic management. Future larger, international studies are planned to test the predictive effect of nadir CD4 cell count, hepatitis C virus infection, gender, ethnicity and HIV viral clade. We recommend the use of this first version for HIV-infected Caucasian men with advanced disease. The clinical management of HIV-positive

persons is increasingly complicated in the era of combination antiretroviral therapy (CART). One aspect of management that requires extensive training relates to the early identification of neurocognitive complications JNK inhibitor of HIV infection. In many countries the general practitioner or the HIV physician is often the primary patient’s interlocutor

[1]. Without specific screening using procedures that are still relatively lengthy selleckchem or require specific training, especially for interpretation [2], physicians may sometimes overlook patients in need of further neurological evaluation. In the CART era, the prevalence of neurocognitive impairment remains high (up to 50% [3]) and HIV-associated neurocognitive disorder (HAND) has shifted towards a milder clinical presentation [4]. Such a mild clinical presentation can escape detection without formal neurological assessment and neuropsychological testing [5]. HAND, even in its mild form, is independently predictive of death [6] as well as HIV-associated dementia [7]. Short-term outcomes include significant impact on independence in daily activities including employment [8], and perhaps most importantly medication adherence [9]. The availability of a tool that can easily be used to predict HAND is therefore necessary.

Here we propose a screening algorithm for HAND that was developed in a sample of 97 HIV-positive individuals with advanced disease. This algorithm was based on risk factors that have been documented for HAND: age [10], educational achievement [11], plasma viral load [12], previous central nervous system (CNS) HIV-related insult [13], haemoglobin levels [14], HIV infection duration [15], Linifanib (ABT-869) CART CNS penetration characteristics [16] and duration of current CART [17]. The development of the screening algorithm was based on support vector machine (SVM) methodology. Because the aim of our study was to provide a simplified algorithm from a complex set of predictors, SVM was the most appropriate procedure [18]. The SVM has been shown to be extremely robust in solving prediction problems while handling large sets of predictors [18]. It is an alternative to more standard statistical techniques such as logistic regression and in certain situations has been found to be superior to logistic regression for finding a robust fit with fewer predictors [18–21].